Literature DB >> 1187950

Conditioned aversion by amphetamine: rates of acquisition and loss of the attenuating effects of prior exposure.

H Cappell, A E Le Blanc.   

Abstract

Chronic prior treatment with amphetamine greatly attenuates the conditined aversion to saccharin that may be produced by amphetamine. Two experiments were designed to determine some of the limiting conditions of this phenomenon. In Experiment 1, chronic treatment with 7.5 mg/kg of amphetamine was administered for 0, 1, 5, or 20 days prior to pairing saccharin with an injection of 1.0 mg/kg of d-amphetamine sulphate. The results indicate that between 5 and 20 days of treatment were necessary for the treatment to be effective in attenuating conditioned aversion. In Experiment 2, rats were withdrawn from treatment with 20 mg/kg of amphetamine for 1, 7, or 14 days prior to conditioning trials with 1.0 mg/kg of amphetamine. The prior treatment lost it effectiveness in attenuating conditioned aversion between 7 and 14 days after withdrawal. Although alternative explanations are possible, the time intervals required for acquisition and loss of the effectiveness of prior treatment are consistent with the hypothesis that tolerance is the mechanism underlying the observed effects.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1187950     DOI: 10.1007/bf00421018

Source DB:  PubMed          Journal:  Psychopharmacologia


  10 in total

1.  An associative analysis of pretreatment effects in gustatory conditioning by amphetamine.

Authors:  C X Poulos; H Cappell
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

2.  The role of injection cues in the production of the morphine preexposure effect in taste aversion learning.

Authors:  Catherine M Davis; Isabel de Brugada; Anthony L Riley
Journal:  Learn Behav       Date:  2010-05       Impact factor: 1.986

3.  Appetitive sensitization by amphetamine does not reduce its ability to produce conditioned taste aversion to saccharin.

Authors:  John Scott-Railton; Gretchen Arnold; Paul Vezina
Journal:  Behav Brain Res       Date:  2006-10-04       Impact factor: 3.332

4.  A comparison of the food intake suppression produced by giving amphetamine as an aversion treatment versus as an anorexic treatment.

Authors:  R J Carey
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

5.  Effects of d-amphetamine on responding simultaneously maintained and punished by presentation of electric shock.

Authors:  J E Barrett
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

6.  Sex differences in the effects of ethanol pre-exposure during adolescence on ethanol-induced conditioned taste aversion in adult rats.

Authors:  Luke K Sherrill; Claire Berthold; Wendy A Koss; Janice M Juraska; Joshua M Gulley
Journal:  Behav Brain Res       Date:  2011-07-08       Impact factor: 3.332

7.  Parametric investigations of the effects of prior exposure to amphetamine and morphine on conditioned gustatory aversion.

Authors:  H Cappell; A E LeBlanc
Journal:  Psychopharmacology (Berl)       Date:  1977-03-16       Impact factor: 4.530

8.  Effects of proximal unconditioned stimulus preexposure on ingestional aversions learned as a result of taste presentation following drug treatment.

Authors:  M Domjan
Journal:  Anim Learn Behav       Date:  1978-05

9.  Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions.

Authors:  Daniel L Albaugh; Jennifer A Rinker; Michael H Baumann; Jacquelyn R Sink; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2011-03-05       Impact factor: 4.530

10.  Ethanol pre-exposure differentially impacts the rewarding and aversive effects of α-pyrrolidinopentiophenone (α-PVP): Implications for drug use and abuse.

Authors:  Katharine H Nelson; Hayley N Manke; Jacob M Bailey; Anna Vlachos; Karina J Maradiaga; Shihui Huang; Tania D Weiss; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2021-10-08       Impact factor: 3.533

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.